FMLI
MRNA icon

Fukoku Mutual Life Insurance’s Moderna MRNA Stock Holding History

Fukoku Mutual Life Insurance’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,933
Closed -$230K – 282
2024
Q2 		$230K Hold
1,933
– – 0.02% 247
2024
Q1 		$206K Buy
+1,933
New +$195K 0.02% 268
2023
Q3 		– Sell
-1,933
Closed -$235K – 295
2023
Q2 		$235K Hold
1,933
– – 0.02% 243
2023
Q1 		$297K Hold
1,933
– – 0.03% 188
2022
Q4 		$347K Buy
1,933
+165
+9% +$27K 0.03% 173
2022
Q3 		$209K Hold
1,768
– – 0.02% 247
2022
Q2 		$253K Hold
1,768
– – 0.02% 228
2022
Q1 		$305K Sell
1,768
-1,600
-48% -$269K 0.02% 226
2021
Q4 		$855K Buy
3,368
+1,688
+100% +$494K 0.06% 101
2021
Q3 		$647K Buy
+1,680
New +$620K 0.05% 126

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fukoku Mutual Life Insurance's MRNA Position: Q3 2024 in Review

Fukoku Mutual Life Insurance sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,933 shares — an estimated $230K sold.

Fukoku Mutual Life Insurance first reported a position in MRNA in Q3 2021 and held it in 10 quarters. The position peaked at $855K in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Fukoku Mutual Life Insurance reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Fukoku Mutual Life Insurance sold 1,933 Moderna shares in Q3 2024, an estimated $230K.
  • Fukoku Mutual Life Insurance first reported a position in Moderna in Q3 2021 and held it in 10 quarters.
  • Fukoku Mutual Life Insurance's Moderna position peaked at $855K in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Fukoku Mutual Life Insurance's 13F filing for Q3 2024, filed 6 Nov 2024.